143 related articles for article (PubMed ID: 629093)
1. [Behavior of the complement components C3 and C4, C-reactive protein and blood sedimentation rate for activity control in arthritis patients during thermo-hydrotherapy].
Günther R; Spath P; Egg D; Geier W; Nachbauer E
Z Rheumatol; 1978; 37(1-2):33-9. PubMed ID: 629093
[TBL] [Abstract][Full Text] [Related]
2. [Elevated C3-proactivator serum levels in patients with chronic polyarthritis].
Stojan B
Z Rheumatol; 1976; 35(7-8):272-7. PubMed ID: 961078
[TBL] [Abstract][Full Text] [Related]
3. [Serum immunoglobulin patterns in rheumatoid arthritis].
Dreher R
Z Rheumatol; 1977; 36(1-2):3-21. PubMed ID: 842145
[TBL] [Abstract][Full Text] [Related]
4. Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation.
Dernellis J; Panaretou M
Am J Cardiol; 2006 Jan; 97(2):245-8. PubMed ID: 16442371
[TBL] [Abstract][Full Text] [Related]
5. [Rheumatoid pericarditis: correlation with immunologic parameters].
Alusík S; Skalická H; Vencovský J; Kohoutová M
Vnitr Lek; 1995 Nov; 41(11):764-6. PubMed ID: 8553595
[TBL] [Abstract][Full Text] [Related]
6. [Complement (C3 and C4) in patients with rheumatoid arthritis during 6 months of treatment with gold salts].
Vlak T; Jajić I
Reumatizam; 1992; 39(1):7-10. PubMed ID: 1366144
[TBL] [Abstract][Full Text] [Related]
7. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
Petersen NE; Elmgreen J; Teisner B; Svehag SE
Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
[TBL] [Abstract][Full Text] [Related]
8. Infliximab treatment reduces complement activation in patients with rheumatoid arthritis.
Familian A; Voskuyl AE; van Mierlo GJ; Heijst HA; Twisk JW; Dijkmans BA; Hack CE
Ann Rheum Dis; 2005 Jul; 64(7):1003-8. PubMed ID: 15958758
[TBL] [Abstract][Full Text] [Related]
9. [No difference in effectiveness measured between treatment in a thermal bath and in an exercise bath in patients with rheumatoid arthritis].
Landewé RB; Peeters R; Verreussel RL; Masek BA; Goei The HS
Ned Tijdschr Geneeskd; 1992 Jan; 136(4):173-6. PubMed ID: 1736128
[TBL] [Abstract][Full Text] [Related]
10. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
Sheĭtanov I; Nikolov K; Petrova P
Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
[TBL] [Abstract][Full Text] [Related]
11. [Changes of the blood sialic acid content and acute phase reactants in open heart surgery].
Chikakiyo H; Oshima I; Kohama T; Nagata J; Yamazaki R; Bando M; Murakami K
Rinsho Byori; 1983 Mar; Suppl 54():89-95. PubMed ID: 6193299
[No Abstract] [Full Text] [Related]
12. Immunologic evaluation of rheumatoid arthritis and therapy with levamisole.
Verhaegen H; de Cree J; de Cock W; Schuermans Y; Engels M; Sonck W
Biomedicine; 1977 Jul; 26(4):283-91. PubMed ID: 922113
[TBL] [Abstract][Full Text] [Related]
13. [A comparative study of serum complement (C3 and C4) in inflammatory joint diseases].
Dacheva V; Dimov DM; Nedialkova V; Koleva P
Vutr Boles; 1990; 29(5):68-74. PubMed ID: 1706901
[TBL] [Abstract][Full Text] [Related]
14. [Fibronectin and other immunologic parameters in chronic polyarthritis].
Siegmeth W; Minar E; Graninger W; Pirich K; Zazgornik J
Z Rheumatol; 1984; 43(1):27-9. PubMed ID: 6201023
[TBL] [Abstract][Full Text] [Related]
15. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate.
Mallya RK; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
J Rheumatol; 1982; 9(2):224-8. PubMed ID: 7097681
[TBL] [Abstract][Full Text] [Related]
16. [The effect of Tauredon on the development of non-specific indicators of inflammatory activity in patients with rheumatoid arthritis].
Vlak T; Jajić Z
Reumatizam; 1992; 39(1):19-22. PubMed ID: 1366140
[TBL] [Abstract][Full Text] [Related]
17. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein.
Molenaar ET; Voskuyl AE; Familian A; van Mierlo GJ; Dijkmans BA; Hack CE
Arthritis Rheum; 2001 May; 44(5):997-1002. PubMed ID: 11352263
[TBL] [Abstract][Full Text] [Related]
18. [Controlled trial of levamisole in rheumatoid arthritis. Clinical and immunological study of 22 cases (author's transl)].
Rondier J; Cayla J; Tron F; Roger M; Bach JF
Nouv Presse Med; 1978 Oct; 7(34):3023-7, 3029-30. PubMed ID: 364409
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
[TBL] [Abstract][Full Text] [Related]
20. Complement activation in acute coronary syndromes.
Iltumur K; Karabulut A; Toprak G; Toprak N
APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
